Jane P. Holmes

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

Journal: The New England journal of medicine

Published: April 22, 2026

Project Optimus for Radiation Therapy-Drug Combinations: Moving Beyond the Maximum Tolerated Dose.

Project Optimus for Radiation Therapy-Drug Combinations: Moving Beyond the Maximum Tolerated Dose.

Journal: International journal of radiation oncology, biology, physics

Published: November 13, 2025

Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial.

Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial.

Journal: Nature medicine

Published: June 17, 2025

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial.

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 08, 2024

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial.

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial.

Journal: The Lancet. Infectious diseases

Published: May 02, 2024

Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial.

Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial.

Journal: Trials

Published: February 02, 2024

Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial.

Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial.

Journal: The British journal of general practice : the journal of the Royal College of General Practitioners

Published: August 25, 2023

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.

Journal: BMJ open

Published: August 07, 2023

Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants.

Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants.

Journal: British journal of clinical pharmacology

Published: April 20, 2023

Repeated squirrelpox infection in Welsh red squirrels.

Repeated squirrelpox infection in Welsh red squirrels.

Journal: The Veterinary record

Published: February 03, 2023

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.

Journal: Lancet (London, England)

Published: November 01, 2022

Visualising harms in publications of randomised controlled trials: consensus and recommendations.

Visualising harms in publications of randomised controlled trials: consensus and recommendations.

Journal: BMJ (Clinical research ed.)

Published: May 16, 2022

Showing 1-12 of 53

Last Updated: 09/26/2026